Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NH600001 vs etomidate for sedation in gastroscopy/colonoscopy
CTR20241478Phase 3Completed
- Sponsor
- Jiangsu Nhwa Pharmaceutical
- Start
- May 2024
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of NH600001 in Not applicable, sponsored by Jiangsu Nhwa Pharmaceutical. Started May 2024; status: completed.
02
Drugs
NH600001
03
Conditions
Not applicable
Beyond the preview
Go deeper on CTR20241478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241478.